{
    "Trade/Device Name(s)": [
        "NIOX VERO",
        "Airway Inflammation Monitor",
        "System, Test, Breath Nitric Oxide"
    ],
    "Submitter Information": "Aerocrine AB",
    "510(k) Number": "K133898",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101034"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "September 23, 2014",
    "Summary Letter Received Date": "September 24, 2014",
    "Submission Date": "November 4, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3080"
    ],
    "Regulation Name(s)": [
        "Breath nitric oxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "allergy"
    ],
    "Analyte(s)": [
        "Nitric Oxide (NO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [
        "Disposable patient filter",
        "Exchangeable handle with NO scrubber filter"
    ],
    "Instrument(s)/Platform(s)": [
        "NIOX VERO unit",
        "Electrochemical NO sensor",
        "NIOX Panel (optional PC application)"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "Quantitative measurement of exhaled nitric oxide"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Accessory",
        "Software",
        "Sensor",
        "Filter"
    ],
    "Document Summary": "FDA 510(k) summary for NIOX VERO system using electrochemical detection to measure nitric oxide in expired breath for evaluation of airway inflammation.",
    "Indications for Use Summary": "Provides non-invasive quantitative measurement of fractional exhaled nitric oxide in expired breath as an adjunct to established clinical and laboratory assessments of asthma patients, for evaluating response to anti-inflammatory therapy in children (7-17 years) and adults (18+ years).",
    "fda_folder": "Toxicology"
}